Bristol-Myers Squibb Company
Cyclohexyl acid pyrazole azoles as LPA antagonists

Abstract:

The present invention provides compounds of Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors. ##STR00001##